(Q70321843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

review article

1 reference

title

von Willebrand disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

author name string

T S Zimmerman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Z M Ruggeri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

publication date

1 February 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

140-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

The subunit structure of normal and hemophilic factor VIII

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Molecular Forms of Antihaemophilic Globulin in Plasma, Cryoprecipitate and after Thrombin Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Disulfide Bonds and the Quaternary Structure of Factor VIII/von Willebrand Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Immunoradiometric assay of procoagulant factor-VIII antigen in plasma and serum and its reduction in haemophilia. Preliminary studies on adult and fetal blood

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Immunoradiometric measurement of the factor VIII procoagulant antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

A variant of factor 8 related antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Inherited variants of factor-VIII-related protein in von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Factor VIII recombination after dissociation by CaCl12.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Factor VIII of small molecular weight and its aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

The Chromatographic Separation of Factor VIII on Aminohexyl Sepharose

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Preparation and properties of bovine factor VIII (antihemophilic factor).

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Characterization of the human factor VIII gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Molecular cloning of a cDNA encoding human antihaemophilic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Cloning and characterization of two cDNAs coding for human von Willebrand factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Structure of human factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Factor VIII, a series of homologous oligomers and a complex of two proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

von Willebrand disease type IIC with different abnormalities of von Willebrand factor in the same sibship

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Failure of AHF concentrate to control bleeding in von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Structure determination of the major asparagine-linked sugar chain of human factor VIII--von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

The effects of neuraminidase treatment on the biological activities of factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Subcellular platelet factor VIII antigen and von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Platelet factor VIII-related antigen: Immunofluorescent localization

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Cultured aortic endothelial cells from pigs with von Willebrand disease: in vitro model for studying the molecular defect(s) of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Binding and release of factor VIII/von Willebrand's factor by human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Synthesis and release of factor VIII by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Synthesis of Factor VIII Antigen by Cultured Guinea Pig Megakaryocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Platelets have more than one binding site for von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Interaction of von Willebrand factor with human platelets in the plasma milieu

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Von Willebrand protein binds to extracellular matrices independently of collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

A Method for Detecting Factor-VIII Clotting Activity Associated with Factor VIII-related Antigen in Agarose Gels

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Studies on the relationship between factor VIII related antigen (VIIIRAg) and factor VIII clotting antigen (VIIICAg) by immunoelectrophoresis and autoradiography using 125I anti VIIICAg

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Urinary excretion of factor VIII after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Radioimmunoassay for coagulant factor VIII-related antigen (VIII:CAg)

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Von Willebrand factor multimer patterns in von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

1-Deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Two Populations of Factor VIII-Related Antigen in a Family with von Willebrand's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

The Factor VIII Abnormality in Severe von Willebrand's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Von Willebrand's disease: combined qualitative and quantitative abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Carbohydrate of the Factor VIII/von Willebrand Factor in von Willebrand's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Acquired von Willebrand's disease, platelet-release defect and angiodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Acquired von Willebrand Syndrome with Inhibitors Both to Factor VIII Clotting Activity and Ristocetin-Induced Platelet Aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Spectrum of von Willebrand's Disease: a study of 100 cases. Italian Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients)

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Detection of Heterozygotes for Recessive von Willebrand's Disease by the Assay of Antihemophilic-Factor-like Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Pool's cryoprecipitate and exhausted plasma in the treatment of von Willebrand's disease and factor-XI deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

DDAVP: alternative to replacement treatment in mild haemophilia A and von Willebrand-Jürgens syndrome (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2887%2980332-5

7 January 2021

10.1016/S0046-8177(87)80332-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3100416%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference